Go to Top

News

Roger Prades at the 28th ECNP Congress: his participation experience

From 29/08 to 1/09, Roger Prades, Iproteos CSO, participated at the 28th ECNP Congress of Applied and Translational Neuroscience. His abstract was selected for poster oral presentation, which was given on 30th of August.

“It has been a very positive experience. Lots of scientists and physicians came around the poster to know a little bit more about IPR19, the cognitive enhancer we are developing at Iproteos”, has declared Roger

Read More

New webpage: ECMED consortium (H2020 MSCT-ITN grant)

The network ECMED has a brand new webpage (http://www.ecmed-itn.eu).

ECMED is a consortium formed by 11 organizations (9 public centres and 2 companies) aimed to design, validate and bring into practice new innovative therapeutic strategies against epilepsy. As well, the consortium seeks to develop a diagnostic approach for the management of this disease.

The consortium’s projects are co-funded by the European Union’s Horizon 2020 research and innovation programme under a

Read More

European project to develop an innovative therapeutic strategy against epilepsy

The biotech Iproteos participates in a project co-funded by the European Union’s Horizon 2020 research and innovation programme under a Marie Sklodowska-Curie grant (No. 645881).

The project, called ECMED (Extracellular Matrix in Epileptogenesis), is aimed to design, validate and bring into practice new innovative therapeutic strategies to further the development of a treatment and a diagnostic approach for the management of epilepsy. It has a duration of three years

Read More

Events

First ECMED Workshop

Next 2-6 November the first ECMED Workshop will take place. ECMED is the acronym for “The Extracellular Matrix in Epileptogenesis” a consortium formed by 11 organizations from all over Europe with a joint objective: to design, validate and bring into practice new innovative therapeutic strategies against epilepsy.

The first workshop, entitled “Understanding epilepsy and Practical workshop 1” will be held in Magdeburg, Germany. Delegates from the consortium members will

Read More

Barcelona BioMed Conference on Blood Brain Barrier

Roger Prades, Iproteos CSO will participate at the Barcelona BioMed Conference “Blood Brain Barrier” that will be held next November 2-4. Roger will give a short talk that will be entitled “IPR19: a prolyl oligopeptidase inhibitor for the treatment of cognitive impairment associated with schizophrenia”. The talk will be delivered on Thursday 3 in the afternoon, at the “Institut d’Estudis Catalans”.

This Barcelona BioMed Conference is organized by Prof.

Read More

Innovation Days – October 2015

Teresa Tarragó will participate at the Innovation Days 2015, a partnering meeting in Open Innovation for Life Sciences. It will take place from 5-6 of October and it is held in Paris. The event features conferences and workshops together with one-to-one partnering meetings.

Iproteos CEO will be on Tuesday 6th of October seeking for partnerships and business opportunities. You can know more about our pipeline, and the potential of

Read More